Neurizon Therapeutics Limited has released a press release.
Epichem gains prestigious international ISO accreditation
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Epichem Awarded Major US Drug Discovery Contract Extension
- MPL successfully reformulated for canine clinical trials
- Chief Executive Officer resigns
- Appendix 4C & Company Update
- PharmAust enters option to license agreement with Elanco
Later from Neurizon Therapeutics
- Appendix 4C & Company Update - June 18
- Reformulation of MPL into tablet form for upcoming trials
- Olivia Newton-John Cancer Reseach Institute collaboration
- PharmAust Progresses Monepantel Tablet Program for Cancer
- PharmAust Develops GMP Method for Monepantel Analogues
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics